कृपया अन्य खोज का प्रयास करें
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Jeanne F. Loring | - | - | Member of Scientific Advisory Board |
Ron Mayron | 60 | 2020 | Independent Director |
Shimon Efrat | - | - | Member of Scientific Advisory Board |
Ronen Twito | 48 | 2020 | Chairman of the Board |
Tamar Galili | 51 | 2022 | Director |
Doron Birger | 72 | 2020 | Independent Director |
Joseph Itskovitz-Eldor | 77 | 2018 | Member of Scientific Advisory Board |
Tamir Ben Hur | - | - | Member of Scientific Advisory Board |
Danielle Melloul | - | - | Member of Scientific Advisory Board |
Eddy Karnieli | - | - | Member of Scientific Advisory Board |
Benjamin Reubinoff | - | - | Member of Scientific Advisory Board |
Liora Oren | 47 | 2022 | External Director |
Olivier Samuel | 50 | 2020 | VP of European Business Development & Director |
Michel Revel | 86 | 2010 | Co-Founder, Chief Scientist, Head of the Scientific Advisory Board & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है